×

Facing depression with botulinum toxin: A randomized controlled trial: Wollmer MA et al.

Journal of Psychiatric Research 46 (2012) 574-581

 

 
Autoren:
M. Axel Wollmer  a,*,
Claas de Boer  
b,
Nadeem Kalak  
a,
Johannes Beck  
a,
Thomas Götz  
a,
Tina Schmidt  
b,
Muris Hodzic  c,
Ursula Bayer  
a,
Thilo Kollmann  
a,
Katja Kollewe  
d,
Daniela Sönmez  
b,
Katja Duntsch  
b,
Martin D. Haug  e,
Manfred Schedlowski  
f,
Martin Hatzinger  
g,
Dirk Dressler  
d,
Serge Brand  
a,
Edith Holsboer-Trachsler  a,
Tillmann H.C. Kruger  b
  
 
 
Autoren-Details:
a  Psychiatric Hospital of the University of Basel, Wilhelm-Klein-Str. 27, 4012 Basel, Switzerland
b  Department of Psychiatry, Social Psychiatry and Psychotherapy, Medical School Hannover, Germany
c  Praxis am Riehenring, Basel, Switzerland
d  Department of Neurology, Medical School Hannover, Germany
e  Department of Plastic, Reconstructive and Aesthetic Surgery, University Hospital Basel, Switzerland
f   Institute of Medical Psychology and Behavioral Immunobiology, University Clinic Essen, Germany
g  Psychiatric Hospital, Solothurn, Switzerland